NCCN Guidelines for Patients® | Chronic Myeloid Leukemia – For Patients | – For Clinicians NCCN Foundation ® gratefully acknowledges our Industry supporters ARIAD Pharmaceuticals, Inc. and Pfizer Inc. for their support in making available these NCCN Guidelines for Patients ® . NCCN independently develops and distributes the NCCN Guidelines for Patients. Our industry supporters do not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content and recommendations contained therein. PAT-N-1018-1017 Chronic Myeloid Leukemia 2018 275 Commerce Drive Suite 300 Fort Washington, PA 19034 215.690.0300 NCCN GUIDELINES FOR PATIENTS ®